Published in Biomark Insights on April 12, 2017
Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A (1998) 192.97
GenePattern 2.0. Nat Genet (2006) 29.07
Treatment of acute lymphoblastic leukemia. N Engl J Med (2006) 11.30
Acute lymphoblastic leukaemia. Lancet (2008) 8.54
A paradigm for class prediction using gene expression profiles. J Comput Biol (2002) 3.64
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia (2009) 2.78
Reprogramming of miRNA networks in cancer and leukemia. Genome Res (2010) 2.65
Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia (2008) 1.67
Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. J Clin Oncol (2003) 1.67
Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia. J Clin Oncol (2005) 1.53
The molecular genetic makeup of acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program (2012) 1.40
Oncomirs: from tumor biology to molecularly targeted anticancer strategies. Mini Rev Med Chem (2009) 1.27
MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia. Haematologica (2011) 1.21
Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia. Blood (2005) 1.20
MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways. Br J Cancer (2013) 1.07
A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL. Hum Mol Genet (2011) 1.07
Pomelo II: finding differentially expressed genes. Nucleic Acids Res (2009) 1.05
Cooperative control of tumor suppressor genes by a network of oncogenic microRNAs. Cell Cycle (2011) 0.99
Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features. Leuk Res (2011) 0.93
Gene expression pattern contributing to prognostic factors in childhood acute lymphoblastic leukemia. Leuk Lymphoma (2012) 0.86
High white blood cell count at diagnosis of childhood acute lymphoblastic leukaemia: biological background and prognostic impact. Results from the NOPHO ALL-92 and ALL-2000 studies. Eur J Haematol (2010) 0.83
Genomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia. Front Med (2014) 0.81
MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours. Mol Cancer (2017) 0.79
Regulation of the expression of zinc finger protein genes by microRNAs enriched within acute lymphoblastic leukemia-derived microvesicles. Genet Mol Res (2015) 0.79
Prospective evaluation of whole genome microRNA expression profiling in childhood acute lymphoblastic leukemia. Biomed Res Int (2014) 0.79
Integrated analysis of gene expression and microRNA regulation in three leukemia-related lymphoblastic cell lines. Gene (2015) 0.78
Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia. Pathol Oncol Res (2014) 0.78
miR expression profiling at diagnosis predicts relapse in pediatric precursor B-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer (2015) 0.77
Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis. Haematologica (2016) 0.77
Molecular Analysis of Central Nervous System Disease Spectrum in Childhood Acute Lymphoblastic Leukemia. Clin Med Insights Oncol (2016) 0.75